# A First-In-Human Study With a Single Ascending Dose of UCB7858 in Healthy Volunteers

> **NCT02879877** · PHASE1 · COMPLETED · sponsor: **UCB Biopharma S.P.R.L.** · enrollment: 78 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** UCB7858
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02879877
- **Lead sponsor:** UCB Biopharma S.P.R.L.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-11
- **Primary completion:** 2018-01-31
- **Final completion:** 2018-01-31
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2019-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02879877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02879877, "A First-In-Human Study With a Single Ascending Dose of UCB7858 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02879877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*